Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 289
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03678493 | A Study of FMT in Patients With AML Allo HSCT in Recipients | ||
| NCT00365287 | Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer | ||
| NCT02765997 | StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies | ||
| NCT03152526 | CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR | ||
| NCT05735717 | MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies | ||
| NCT04363346 | Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia | ||
| NCT03998735 | Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure | ||
| NCT00309842 | Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases | ||
| NCT01385423 | Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML) | ||
| NCT01464359 | T-Cell Depleted Double UCB for Refractory AML | ||
| NCT04284254 | MT2018-18: Sleeping Beauty Transposon-Engineered Plasmablasts for Hurler Syndrome Post Allo HSCT | ||
| NCT00006451 | Bone Marrow Transplantation in Treating Patients With Leukemia | ||
| NCT04105270 | RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial | ||
| NCT00680667 | Clinical Trial of Trametes Versicolor in Women With Breast Cancer | ||
| NCT00668564 | Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism | ||
| NCT04629209 | A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma | ||
| NCT00176852 | Stem Cell Transplant for Hemoglobinopathy | ||
| NCT00630565 | Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | ||
| NCT00176904 | Stem Cell Transplant for Inborn Errors of Metabolism | ||
| NCT05322408 | HCW9218 in Select Advanced Solid Tumors | ||
| NCT06792825 | HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL | ||
| NCT00889408 | DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma | ||
| NCT05308316 | Sugars in Cigarettes | ||
| NCT02141451 | ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL | ||
| NCT05447156 | QuitGuide for American Indians: Aims 2 & 3 | ||
| NCT00376519 | Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases | ||
| NCT04969783 | Telehealth-Filter Ventilation ( COMET2P1 ) | ||
| NCT00352118 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | ||
| NCT01885897 | IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT | ||
| NCT00357565 | Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia | ||
| NCT05502302 | App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer | ||
| NCT00176839 | Stem Cell Transplantation for Hematological Malignancies | ||
| NCT01106950 | Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML) | ||
| NCT01343368 | Preservation of Ovarian Function After Hematopoietic Cell Transplant | ||
| NCT01593618 | Empowering Cancer Survivors Through Information Technology | ||
| NCT00281827 | Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer | ||
| NCT02042924 | Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies | ||
| NCT02161783 | Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation | ||
| NCT04055844 | Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS | ||
| NCT00630253 | Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia | ||
| NCT06872333 | Allo HSCT for High Risk Hemoglobinopathies | ||
| NCT04090606 | Tobacco Constituents and Biomarkers | ||
| NCT05643014 | Observational Study of Exposure to Environmental Toxicants Among Firefighters | ||
| NCT00622674 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | ||
| NCT00346125 | PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma | ||
| NCT01566682 | A Multi-Center Trial of the ProLung Test™ | ||
| NCT01288222 | Selecting a Favorable KIR Donor in Unrelated HCT for AML | ||
| NCT05025774 | Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise | ||
| NCT06412497 | MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure. | ||
| NCT06772090 | Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies |
